Clinicopathological features of CpG island methylator phenotype‐positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
CpG island methylator phenotype (CIMP) is a recently described subset of colorectal cancers (CRC) with widespread methylation of multiple promoter CpG islands. But the prognostic implication of CIMP in CRC has not been clarified. Thus, the aim of the present study was to differentiate the unique characteristics of CIMP from those of microsatellite instability (MSI)‐high CRC, especially with regard to prognosis. CIMP, MSI, and mutations of KRAS codons 12 and 13 and of BRAF codon 600 were evaluated in 134 sporadic CRC. Patient survival and other clinicopathological variables were correlated with CIMP or genetic changes. High CIMP, high MSI, and mutations in KRAS or BRAF were detected in 31.3%, 14.2%, 33.6%, and 4.5% of overall CRC, respectively. High CIMP was closely associated with MSI and BRAF mutation but not with KRAS mutation. CIMP‐high, microsatellite‐stable (MSS) CRC were significantly associated with proximal location and nodal metastasis and had close but non‐significant associations with liver metastasis. A worse clinical outcome was found for CIMP‐high, MSS CRC with KRAS/BRAF mutation but not for those lacking KRAS/BRAF mutation. The findings support the contention that CIMP‐high CRC have distinct clinicopathological and epidemiological features and suggest that the alleged poor clinical outcome of CIMP‐high CRC patients is closely associated with the presence of KRAS/BRAF mutation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RAF/RAS oncogenes and mismatch-repair status
Rajagopalan, H., Bardelli, A., Lengauer, C., Kinzler, K. W., Vogelstein, B., & Velculescu, V. E. (2002) · Nature · doi:10.1038/418934a · Cited by 1,224
Cited by
Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers
Okugawa, Y., Grady, W. M., & Goel, A. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.07.011 · Cited by 782
Ogino, S., Nosho, K., Kirkner, G. J., Kawasaki, T., Meyerhardt, J. A., Loda, M., Giovannucci, E. L., & Fuchs, C. S. (2009) · Gut · doi:10.1136/gut.2008.155473 · Cited by 777
Association Between Molecular Subtypes of Colorectal Cancer and Patient Survival
Phipps, A. I., Limburg, P. J., Baron, J. A., Burnett-Hartman, A. N., Weisenberger, D. J., Laird, P. W., Sinicrope, F. A., Rosty, C., Buchanan, D. D., Potter, J. D., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.09.038 · Cited by 401
CIMP Status of Interval Colon Cancers: Another Piece to the Puzzle
Arain, M. A., Sawhney, M., Sheikh, S., Anway, R., Thyagarajan, B., Bond, J. H., & Shaukat, A. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.699 · Cited by 382
Guastadisegni, C., Colafranceschi, M., Ottini, L., & Dogliotti, E. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.05.009 · Cited by 380
Metadata
- Authors
- Lee, S., Cho, N., Choi, M., Yoo, E. J., Kim, J., & Kang, G. H.
- Venue
- Pathology International
- Publisher
- Wiley
- Published
- 2008-01-10
- Volume
- 58
- Issue
- 2
- Pages
- 104-113
- ISSN
- 1320-5463 (ISSN-L)
- 1440-1827
- OpenAlex
- W1939927669
- Cited by
- 136
- References
- 1
- FWCI
- 6.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinicopathological features of CpG island methylator phenotype‐positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation. https://app.cochat.ai/papers/10.1111/j.1440-1827.2007.02197.x
- The paper
- Lee, S., Cho, N., Choi, M., Yoo, E. J., Kim, J., & Kang, G. H. (2008). Clinicopathological features of CpG island methylator phenotype‐positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation. Pathology International. https://doi.org/10.1111/j.1440-1827.2007.02197.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.